Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases

Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases

Introduction The prevalence of immune-mediated diseases has increased in the past decades and despite the use of biological treatments all patients do not achieve remission. The aim of this study was to characterise the reasons for short interruptions during treatment with two commonly used TNF-inhi...

Full description

Bibliographic Details
Main Authors: Tea Lamberg, Taina Sipponen, Sanna Valtanen, Kari K Eklund, Tarja Mälkönen, Kristiina Aalto, Katriina Mikola, Kaija-Leena Kolho, Sanna Leinonen, Pia Isomäki, Heidi Mäkinen, Krista-Liisa Vidqvist, Arto Kokko, Laura Huilaja, Minna Kyllönen, Paula Keskitalo, Sirja Sard, Paula Vähäsalo, Ritva Koskela, Liisa Kröger, Perttu Lahtinen, Anna-Maija Haapala, Katja Korkatti, Tuulikki Sokka-Isler, T. Sakari Jokiranta
Format: Article
Language:English
Published: Taylor & Francis Group 2022-07-01
Series:Autoimmunity
Subjects:
infliximab
adalimumab
crohn disease
ulcerative colitis
rheumatoid arthritis
juvenile idiopathic arthritis
immunisation
treatment interruption
Online Access:http://dx.doi.org/10.1080/08916934.2022.2067985

Internet

http://dx.doi.org/10.1080/08916934.2022.2067985

Similar Items